Global Pharma-Grade Hyaluronic Acid Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Pharma-Grade Hyaluronic Acid Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Hyaluronic acid is a naturally occurring substance that helps retain moisture in the skin and eyes and lubricates the joints. Pharma-Grade Hyaluronic Acid is generally used in pharmaceutical formulations, such as Injection Product and Eye Drops for osteoarthritis of the knee joint. Hyaluronic acid also called hyaluronan, is an anionic, nonsulfated glycosaminoglycan distributed widely throughout connective, epithelial, and neural tissues. It is unique among glycosaminoglycans in that it is nonsulfated, forms in the plasma membrane instead of the Golgi apparatus, and can be very largehuman synovial HA averages about 7 million Da per molecule, or about 20000 disaccharide monomers, while other sources mention 3–4 million Da. As one of the chief components of the extracellular matrix, hyaluronan contributes significantly to cell proliferation and migration, and may also be involved in the progression of some malignant tumors.
Pharma-Grade Hyaluronic Acid report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pharma-Grade Hyaluronic Acid market is projected to reach US$ 330 million in 2034, increasing from US$ 162.8 million in 2022, with the CAGR of 10.3% during the period of 2024 to 2034. Demand from Injection Product and Eye Drops are the major drivers for the industry.
Global key players of pharma-grade hyaluronic acid include Bloomage Biotech, HTL Biotechnology, Kewpie, Contipro, Fidia Farmaceutici, etc. The top five players hold a share about 78%. Europe is the largest market, has a share about 51%, followed by North America and Asia-Pacific , with share 26% and 21%, separately.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pharma-Grade Hyaluronic Acid market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Bloomage Biotech
AWA Biopharm
Kewpie
Contipro
Seikagaku
HTL Biotechnology
Fidia Farmaceutici
Segment by Type
Microbial Fermentation
Animal Tissue
Injection Product
Eye Drops
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pharma-Grade Hyaluronic Acid market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pharma-Grade Hyaluronic Acid, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pharma-Grade Hyaluronic Acid industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pharma-Grade Hyaluronic Acid in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pharma-Grade Hyaluronic Acid introduction, etc. Pharma-Grade Hyaluronic Acid Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Pharma-Grade Hyaluronic Acid market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Pharma-Grade Hyaluronic Acid report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pharma-Grade Hyaluronic Acid market is projected to reach US$ 330 million in 2034, increasing from US$ 162.8 million in 2022, with the CAGR of 10.3% during the period of 2024 to 2034. Demand from Injection Product and Eye Drops are the major drivers for the industry.
Global key players of pharma-grade hyaluronic acid include Bloomage Biotech, HTL Biotechnology, Kewpie, Contipro, Fidia Farmaceutici, etc. The top five players hold a share about 78%. Europe is the largest market, has a share about 51%, followed by North America and Asia-Pacific , with share 26% and 21%, separately.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pharma-Grade Hyaluronic Acid market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bloomage Biotech
AWA Biopharm
Kewpie
Contipro
Seikagaku
HTL Biotechnology
Fidia Farmaceutici
Segment by Type
Microbial Fermentation
Animal Tissue
Segment by Application
Injection Product
Eye Drops
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pharma-Grade Hyaluronic Acid market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pharma-Grade Hyaluronic Acid, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pharma-Grade Hyaluronic Acid industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pharma-Grade Hyaluronic Acid in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pharma-Grade Hyaluronic Acid introduction, etc. Pharma-Grade Hyaluronic Acid Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Pharma-Grade Hyaluronic Acid market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices